Although studies have repeatedly shown the benefits of S1R agonists in protecting photoreceptors and ganglion cells [15,16], these effects on retinal neurons may not be extrapolatable to AMD pathology that intimately involves the RPE, a highly specialized non-neuronal tissue [26]. This evidence concerns the gene TMBIM4 and age-related macular degeneration.